PharmacoEconomics

, Volume 9, Supplement 3, pp 46–49 | Cite as

Influenza in The Netherlands

  • J. André Knottnerus
Section 2: Economic Impact of Influenza

Summary

This paper reports on the occurrence of influenza and the associated burden of illness in The Netherlands. In addition, attention is paid to the effectiveness of vaccination, vaccination status and the national strategy to raise the vaccination rate among risk groups.

The incidence of influenza in the community appears to be 3 to 6 times higher than the incidence observed in general practice, since most cases do not present to the general practitioner (GP). Annually, 15 000 to 30 000 hospital admissions (1 to 2 per 1000 inhabitants) and 2000 to 2200 deaths (1.3 to 1.5 per 10 000), mostly among the elderly, are related to influenza. Vaccination has been shown to prevent about 50% of the influenza cases. Between 1991 and 1994 the vaccination rate among risk groups increased from 28 to 43%. In this period, a very active campaign was mounted.

Much energy is being invested in further raising the vaccination rate among risk groups, with GPs holding a key position. In addition, the Dutch Health Council advises vaccination for persons ~ 65 years of age.

Keywords

Influenza Adis International Limited Influenza Vaccination Vaccination Rate Vaccination Status 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Nederlands Instituut voor onderzoek van de eerstelijnsgezondheidszorg (NIVEL). Continue Morbiditeits Registratie Peilstations Nederland. Utrecht: NIVEL, 1991Google Scholar
  2. 2.
    Classification Committee of WONCA. ICHPPC–2–defined. Inclusion criteria of the rubrics of the International Classification of Health Problems in Primary Care. Oxford: Oxford University Press, 1983Google Scholar
  3. 3.
    Govaert THME. Influenza bij ouderen. Thesis. Maastricht: University of Limburg, 1994Google Scholar
  4. 4.
    Govaert THME, Thijs CTMCN, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals. A randomized double–blind placebo–controlled trial. JAMA 1994; 272: 1661–5PubMedCrossRefGoogle Scholar
  5. 5.
    Centraal Bureau voor de Statistiek. Vademecum Gezondheidstatistiek Nederland. Den Haag: CBS–publicaties 1992/89Google Scholar
  6. 6.
    Sprenger MJW. The impact of influenza; an epidemiological study of morbidity, direct mortality and related mortality [thesis]. Rotterdam: Erasmus University, 1990Google Scholar
  7. 7.
    Meynaar JA, Wout JW van het, Vandenbroucke JP, et al. Vaccinatie tegen influenza: aanmoedigen of afzien? Ned Tijdschr Geneeskd 1992; 136: 168–72PubMedGoogle Scholar
  8. 8.
    Govaert THME, Dinant GJ, Sprenger MJW, et al. Adverse effects of influenza vaccination. A randomized, double–blind placebo–controlled trial. BMJ 1993; 307: 988–90PubMedCrossRefGoogle Scholar
  9. 9.
    Gross PA, Quinnan GV, Rodstein M, et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Arch Intern Med 1988; 148: 562–5PubMedCrossRefGoogle Scholar
  10. 10.
    Nicol KL, Margolis KL, Wuorenma RN, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Eng J Med 1994; 331: 778–84CrossRefGoogle Scholar
  11. 11.
    Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost effectiveness in ahealth maintenance organization. Ann Intern Med 1994; 121: 947–52PubMedGoogle Scholar
  12. 12.
    Ahmed AH, Nicholson KG, Nguyen-Van-Tam JS. Reduction in mortality associated with influenza vaccine during 1989-1990 epidemic. Lancet 1995; 346: 591–65PubMedCrossRefGoogle Scholar
  13. 13.
    Wulp CG van der, Perenboom RJM, Davidse W. Ontwikkelingen in de griepvaccinatie in Nederland [Developmentsof the influenza–vaccination in The Netherlands]. Mndber Gezondheid (CBS); 1995/2: 4–8Google Scholar
  14. 14.
    Influenza Standard, M35, 1993. In: NHG Standaarden. Richtlijnen voor het handelen en de praktijkvoering van de huisarts [NHG Standards. Guidelines for the management and the practice of the general practitioner]. NHG Utrecht: Nederlands Huisartsen Genootschap 1989-1995Google Scholar
  15. 15.
    Davidse W, Perenboom RJM. Verhoging van de vaccinatiegraad tegen influenza bij risicopatienten doorgerichte uitnodiging in de eerstelijn. Ned Tijdschr Geneesk 1995; 139: 2149–52Google Scholar

Copyright information

© Adis International Limited 1996

Authors and Affiliations

  • J. André Knottnerus
    • 1
  1. 1.Department of General PracticeUniversity of LimburgThe Netherlands

Personalised recommendations